Sanofi, Glaxo advance talks to supply up to 300 mln COVID-19 vaccine does to Europe -companies
July 31 (Reuters) - Sanofi SA and GlaxoSmithKline Plc on Friday said they are in advanced discussions with the European Commission to supply up to 300 million doses of the drugmakers's experimental COVID-19 vaccine.The doses would be manufactured...
Read more